The Indianapolis-based animal health biotech company announced that the USDA’s Center for Veterinary Biologics (USDA CVB) has granted conditional licensure for Clostridium Perfringens Alpha Toxin and NetB Antibody Fragment, Live Limosilactobacillus Vector (CPerf LLV) – previously referred to as BE-101 – based on the demonstration of a reasonable expectation of efficacy in terms of reduced necrotic enteritis (NE)-associated mortality in broiler chickens challenged with Clostridium perfringens. BiomEdit said it will continue advancing CPerf LLV toward full licensure.